Page last updated: 2024-09-02

thromboxanes and Colorectal Neoplasms

thromboxanes has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Patrono, C1
Ainsworth, NL; Armstrong, AC; Bradbury, J; Cafferty, FH; Cameron, DA; Capaldi, LM; Churn, M; Cleary, S; Cunningham, D; Dawson, LK; Eaton, JD; Eichholz, A; Gentry-Maharaj, A; Gilbert, DC; Hatem, D; Herbertson, RA; Horan, G; Hubner, RA; Joharatnam-Hogan, N; Kagzi, MM; Khoo, V; Kunene, VL; Kynaston, HG; Langley, RE; Lofts, FJ; MacKenzie, M; Meade, A; Mullen, R; Narahari, K; O'Callaghan, A; Patrono, C; Patterson, DM; Petrucci, G; Ring, A; Rizvi, AJ; Robbins, A; Rocca, B; Scott-Brown, MWG; Sothi, S; Srihari, N; Stokes, Z; Swinson, DEB; Walker, GA; Walther, A; Wheatley, DA; Wilson, RH1

Reviews

1 review(s) available for thromboxanes and Colorectal Neoplasms

ArticleYear
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 386, Issue:2

    Topics: Aspirin; Carcinogenesis; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gastrointestinal Neoplasms; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboxanes

2023

Trials

1 trial(s) available for thromboxanes and Colorectal Neoplasms

ArticleYear
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
    British journal of cancer, 2023, Volume: 129, Issue:4

    Topics: Aspirin; Biomarkers; Colorectal Neoplasms; Creatinine; Female; Humans; Male; Middle Aged; Thromboxanes

2023